Cash Flow Statement

Amortization Amortization Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Growth Metrics

Others

Amortization - Goodwill Cost of Revenue EBIAT Gross Profit Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Receivables - Net Receivables - Other Rent Expense Shares Outstanding Shares Outstanding Wages, Salaries and Other

Avricore Health (AVCRF) Shares Issued (2016 - 2024)

Avricore Health has reported Shares Issued over the past 10 years, most recently at $12527.4 for Q4 2024.

Quarterly Shares Issued changed N/A to $12527.4 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $63320.8 through Dec 2024, up 100.96% year-over-year, with the annual reading at $63252.6 for FY2024, 100.8% up from the prior year.
Shares Issued was $12527.4 for Q4 2024 at Avricore Health, down from $38485.3 in the prior quarter.
Over five years, Shares Issued peaked at $1.8 million in Q4 2021 and troughed at -$6900.7 in Q3 2022.
The 4-year median for Shares Issued is $18947.4 (2022), against an average of $158730.7.
Year-over-year, Shares Issued crashed 317.17% in 2022 and then grew 7.36% in 2023.
A 4-year view of Shares Issued shows it stood at $1.8 million in 2021, then crashed by 97.35% to $47885.7 in 2022, then plummeted by 76.68% to $11166.8 in 2023, then increased by 12.18% to $12527.4 in 2024.
Per Business Quant, the three most recent readings for AVCRF's Shares Issued are $12527.4 (Q4 2024), $38485.3 (Q3 2024), and $731.14 (Q2 2024).